Patients with functional mitral regurgitation (FMR) who underwent transcatheter edge-to-edge repair (TEER) with a PASCAL device showed durable MR reduction, a high survival rate and low incidence of major adverse events, and sustained functional and quality-of-life improvements, a new analysis shows.